vs
雅培（ABT）与NATIONAL HEALTHCARE CORP（NHC）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是NATIONAL HEALTHCARE CORP的29.6倍（$11.5B vs $386.5M）。雅培净利率更高（15.5% vs 6.4%，领先9.1%）。NATIONAL HEALTHCARE CORP同比增速更快（4.6% vs 4.4%）。雅培自由现金流更多（$2.6B vs $6.4M）。过去两年NATIONAL HEALTHCARE CORP的营收复合增速更高（14.0% vs 7.2%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
HCA Healthcare是1968年成立的美国营利性医疗服务运营商，总部位于田纳西州纳什维尔。截至2020年5月，该公司在全美20个州及英国持有并运营186家医院，还有约2400个医疗服务网点，涵盖手术中心、独立急诊室、紧急护理中心及医师诊所，2024年位列美国财富500强第61位。
ABT vs NHC — 直观对比
营收规模更大
ABT
是对方的29.6倍
$386.5M
营收增速更快
NHC
高出0.2%
4.4%
净利率更高
ABT
高出9.1%
6.4%
自由现金流更多
ABT
多$2.6B
$6.4M
两年增速更快
NHC
近两年复合增速
7.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $386.5M |
| 净利润 | $1.8B | $24.8M |
| 毛利率 | 57.0% | — |
| 营业利润率 | 19.6% | 8.6% |
| 净利率 | 15.5% | 6.4% |
| 营收同比 | 4.4% | 4.6% |
| 净利润同比 | -80.8% | 308.6% |
| 每股收益（稀释后） | $1.01 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTNHC
| Q4 25 | $11.5B | $386.5M | ||
| Q3 25 | $11.4B | $382.7M | ||
| Q2 25 | $11.1B | $374.9M | ||
| Q1 25 | $10.4B | $373.7M | ||
| Q4 24 | $11.0B | $369.4M | ||
| Q3 24 | $10.6B | $340.2M | ||
| Q2 24 | $10.4B | $300.7M | ||
| Q1 24 | $10.0B | $297.2M |
净利润ABTNHC
| Q4 25 | $1.8B | $24.8M | ||
| Q3 25 | $1.6B | $39.2M | ||
| Q2 25 | $1.8B | $23.7M | ||
| Q1 25 | $1.3B | $32.2M | ||
| Q4 24 | $9.2B | $6.1M | ||
| Q3 24 | $1.6B | $42.8M | ||
| Q2 24 | $1.3B | $26.8M | ||
| Q1 24 | $1.2B | $26.2M |
毛利率ABTNHC
| Q4 25 | 57.0% | — | ||
| Q3 25 | 55.4% | — | ||
| Q2 25 | 56.4% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | 55.2% | — |
营业利润率ABTNHC
| Q4 25 | 19.6% | 8.6% | ||
| Q3 25 | 18.1% | 7.9% | ||
| Q2 25 | 18.4% | 9.1% | ||
| Q1 25 | 16.3% | 8.2% | ||
| Q4 24 | 17.4% | 7.8% | ||
| Q3 24 | 17.5% | 6.7% | ||
| Q2 24 | 16.1% | 7.5% | ||
| Q1 24 | 13.9% | 5.3% |
净利率ABTNHC
| Q4 25 | 15.5% | 6.4% | ||
| Q3 25 | 14.5% | 10.3% | ||
| Q2 25 | 16.0% | 6.3% | ||
| Q1 25 | 12.8% | 8.6% | ||
| Q4 24 | 84.1% | 1.6% | ||
| Q3 24 | 15.5% | 12.6% | ||
| Q2 24 | 12.5% | 8.9% | ||
| Q1 24 | 12.3% | 8.8% |
每股收益（稀释后）ABTNHC
| Q4 25 | $1.01 | $1.58 | ||
| Q3 25 | $0.94 | $2.50 | ||
| Q2 25 | $1.01 | $1.52 | ||
| Q1 25 | $0.76 | $2.07 | ||
| Q4 24 | $5.26 | $0.38 | ||
| Q3 24 | $0.94 | $2.73 | ||
| Q2 24 | $0.74 | $1.73 | ||
| Q1 24 | $0.70 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $92.8M |
| 总债务越低越好 | $12.9B | $40.0M |
| 股东权益账面价值 | $52.1B | $1.1B |
| 总资产 | $86.7B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.25× | 0.04× |
8季度趋势，按日历期对齐
现金及短期投资ABTNHC
| Q4 25 | $8.9B | $92.8M | ||
| Q3 25 | $7.7B | $130.6M | ||
| Q2 25 | $7.3B | $111.0M | ||
| Q1 25 | $6.8B | $90.4M | ||
| Q4 24 | $8.0B | $76.1M | ||
| Q3 24 | $7.8B | $84.8M | ||
| Q2 24 | $7.2B | $136.2M | ||
| Q1 24 | $6.7B | $94.0M |
总债务ABTNHC
| Q4 25 | $12.9B | $40.0M | ||
| Q3 25 | — | $73.1M | ||
| Q2 25 | — | $110.0M | ||
| Q1 25 | — | $134.0M | ||
| Q4 24 | $14.1B | $137.0M | ||
| Q3 24 | — | $147.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABTNHC
| Q4 25 | $52.1B | $1.1B | ||
| Q3 25 | $51.0B | $1.1B | ||
| Q2 25 | $50.6B | $1.0B | ||
| Q1 25 | $48.8B | $1.0B | ||
| Q4 24 | $47.7B | $980.2M | ||
| Q3 24 | $39.8B | $983.5M | ||
| Q2 24 | $39.3B | $945.8M | ||
| Q1 24 | $38.8B | $924.7M |
总资产ABTNHC
| Q4 25 | $86.7B | $1.5B | ||
| Q3 25 | $84.2B | $1.6B | ||
| Q2 25 | $84.0B | $1.6B | ||
| Q1 25 | $81.4B | $1.5B | ||
| Q4 24 | $81.4B | $1.5B | ||
| Q3 24 | $74.4B | $1.6B | ||
| Q2 24 | $73.0B | $1.3B | ||
| Q1 24 | $72.5B | $1.3B |
负债/权益比ABTNHC
| Q4 25 | 0.25× | 0.04× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | 0.30× | 0.14× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $16.8M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $6.4M |
| 自由现金流率自由现金流/营收 | 22.9% | 1.7% |
| 资本支出强度资本支出/营收 | 6.0% | 2.7% |
| 现金转化率经营现金流/净利润 | 1.87× | 0.68× |
| 过去12个月自由现金流最近4个季度 | $7.4B | $148.6M |
8季度趋势，按日历期对齐
经营现金流ABTNHC
| Q4 25 | $3.3B | $16.8M | ||
| Q3 25 | $2.8B | $66.2M | ||
| Q2 25 | $2.0B | $62.8M | ||
| Q1 25 | $1.4B | $39.3M | ||
| Q4 24 | $2.9B | $12.8M | ||
| Q3 24 | $2.7B | $34.2M | ||
| Q2 24 | $2.0B | $50.7M | ||
| Q1 24 | $1.0B | $9.6M |
自由现金流ABTNHC
| Q4 25 | $2.6B | $6.4M | ||
| Q3 25 | $2.3B | $56.5M | ||
| Q2 25 | $1.5B | $52.6M | ||
| Q1 25 | $933.0M | $33.1M | ||
| Q4 24 | $2.1B | $4.6M | ||
| Q3 24 | $2.1B | $28.6M | ||
| Q2 24 | $1.4B | $42.8M | ||
| Q1 24 | $627.0M | $3.7M |
自由现金流率ABTNHC
| Q4 25 | 22.9% | 1.7% | ||
| Q3 25 | 20.2% | 14.8% | ||
| Q2 25 | 13.9% | 14.0% | ||
| Q1 25 | 9.0% | 8.9% | ||
| Q4 24 | 19.6% | 1.3% | ||
| Q3 24 | 20.2% | 8.4% | ||
| Q2 24 | 13.8% | 14.2% | ||
| Q1 24 | 6.3% | 1.2% |
资本支出强度ABTNHC
| Q4 25 | 6.0% | 2.7% | ||
| Q3 25 | 4.4% | 2.5% | ||
| Q2 25 | 4.5% | 2.7% | ||
| Q1 25 | 4.7% | 1.6% | ||
| Q4 24 | 6.6% | 2.2% | ||
| Q3 24 | 5.2% | 1.7% | ||
| Q2 24 | 5.1% | 2.6% | ||
| Q1 24 | 4.0% | 2.0% |
现金转化率ABTNHC
| Q4 25 | 1.87× | 0.68× | ||
| Q3 25 | 1.70× | 1.69× | ||
| Q2 25 | 1.15× | 2.65× | ||
| Q1 25 | 1.07× | 1.22× | ||
| Q4 24 | 0.31× | 2.10× | ||
| Q3 24 | 1.64× | 0.80× | ||
| Q2 24 | 1.51× | 1.89× | ||
| Q1 24 | 0.84× | 0.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
NHC
| Inpatient Services Segment | $333.7M | 86% |
| Homecare Services Segment | $40.0M | 10% |
| Other | $11.2M | 3% |
| National | $1.6M | 0% |
